(Q42440224)

31 October 2017

title

Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance (English)

1 reference

31 October 2017

1 reference

2

1 reference

31 October 2017

4

1 reference

31 October 2017

Rocío García de la Garza

Rocío García de la Garza

1

0 references

Mercedes Iñarrairaegui

Mercedes Iñarrairaegui

9

0 references

Bruno Sangro

Bruno Sangro

10

0 references

Delia D'Avola

5

Delia D'Avola

1 reference

31 October 2017

8

Leyre Silva

1 reference

31 October 2017

6

Virginia Belsue

1 reference

31 October 2017

Juana Merino

3

1 reference

31 October 2017

José A Delgado

7

1 reference

31 October 2017

Jesus J Sola

11

1 reference

31 October 2017

Fernando Pardo

12

1 reference

31 October 2017

Jorge Quiroga

13

1 reference

31 October 2017

J Ignacio Herrero

14

1 reference

31 October 2017

language of work or name

1 reference

26 July 2013

1 reference

31 October 2017

published in

Liver Transplantation

1 reference

31 October 2017

volume

19

1 reference

31 October 2017

issue

9

1 reference

31 October 2017

page(s)

937-944

1 reference

Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients.

31 October 2017

cites work

1 reference

Hot-topic debate on tolerance: immunosuppression withdrawal

21 January 2018

1 reference

Long-term outcome after liver transplantation

21 January 2018

1 reference

What is the real gain after liver transplantation?

21 January 2018

1 reference

Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study

21 January 2018

1 reference

Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial

21 January 2018

1 reference

Minimization of immunosuppression in adult liver transplantation: new strategies and tools

21 January 2018

1 reference

Improvement of renal function after conversion to mycophenolate mofetil combined with low-level calcineurin inhibitor in liver transplant recipients with chronic renal dysfunction

21 January 2018

1 reference

Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation

21 January 2018

1 reference

Actively acquired tolerance of foreign cells

21 January 2018

1 reference

Tolerance induction in clinical transplantation

21 January 2018

1 reference

Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs

21 January 2018

1 reference

Weaning of immunosuppression in liver transplant recipients

21 January 2018

1 reference

Operational tolerance after liver transplantation

21 January 2018

1 reference

Operational tolerance in clinical liver transplantation: emerging developments

21 January 2018

1 reference

Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence

21 January 2018

1 reference

Weaning of immunosuppression in living donor liver transplant recipients

21 January 2018

1 reference

Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation

21 January 2018

1 reference

Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants

21 January 2018

1 reference

FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.

21 January 2018

1 reference

Multiparameter immune profiling of operational tolerance in liver transplantation

21 January 2018

1 reference

Harmonization of immune biomarker assays for clinical studies

21 January 2018

1 reference

ImmuKnow: a new parameter in immune monitoring of pediatric liver transplantation recipients.

21 January 2018

1 reference

Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis

21 January 2018

1 reference

ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis.

21 January 2018

1 reference

The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study

21 January 2018

1 reference

Analysis of in vitro lymphocyte proliferation as a screening tool for cellular immunodeficiency

21 January 2018

1 reference

Prognostic model for early acute rejection after liver transplantation.

21 January 2018

1 reference

Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome.

21 January 2018

1 reference

Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients

21 January 2018

1 reference

Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.

21 January 2018

1 reference

Tolerance: is it worth the risk?

21 January 2018

1 reference

The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation

21 January 2018

1 reference

Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance

21 January 2018

1 reference

Defining the outcome of immunosuppression withdrawal after liver transplantation

21 January 2018

1 reference

Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: The effect of smoking withdrawal

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/LT.23686

1 reference

31 October 2017

1 reference